OpenVSafe by OpenVAERS
Search V-safe

6BH-20255-64939

2 vaccinations 13 coded responses 23 check-ins 13 free-text entries 5 call cases
Sex
Female
Age at first dose
46-50
ZIP prefix
210 / MD
Registered
2020-12-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-23
    Registered in v-safe
  2. 2020-12-23
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-24
    Survey response — days 1–6 daily, dose 1
    MedDRA: Asthenia, Dizziness, Malaise — Feeling: Poor · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Malaise, lightheaded, weak
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2020-12-24
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain, Swelling · Headache, Nausea
    Adult check-in
  6. 2020-12-26
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2020-12-26
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  8. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache
    Adult check-in
  9. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  10. 2020-12-29
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  11. 2020-12-30
    Survey response — day 7, dose 1
    MedDRA: Rhinitis — Feeling: Fair · Muscle or body aches, Fatigue or tiredness
    Free text: Rhinitis
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-06
    Survey response — day 14, dose 1
    MedDRA: Headache, Pain, Rhinitis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Worse rhinitis and more aches and pains with a headache that doesn't seem to go away.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-06
    Report sent to call center — day 14, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  14. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  15. 2021-01-11
    Health check-in — day 0, dose 2
    Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-01-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dyspnoea, Nasal congestion — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities
    Free text: Stuffie nose hard time getting breath at times
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-12
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  18. 2021-01-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities
    Free text: supraclavicular lymph node Swollen (5” x 2”)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-01-13
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  20. 2021-01-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Joint pains, Muscle or body aches
    Free text: supraclavicular lymph node swelling
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-01-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Itching · Headache, Joint pains
    Free text: supraclavicular lymph node swollen
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-01-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Swelling · Headache, Joint pains
    Free text: supraclavicular lymph node Swollen
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-01-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches
    Free text: supraclavicular lymph node swollen
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-01-18
    Survey response — day 7, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Headache, Joint pains
    Free text: supraclavicular lymph node swollen
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  25. 2021-01-27
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  26. 2021-02-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-02-17
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-02-24
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-04-12
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  30. 2021-07-12
    Survey response — 6 months, dose 2
    MedDRA: Arthralgia, Fatigue — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Constant joint pains, extreme fatigue
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  31. 2022-01-11
    Survey response — 12 months, dose 2
    MedDRA: Adenocarcinoma, Neoplasm malignant, Swelling — Feeling: Poor · Be unable to work or attend school
    Free text: Cancer the Supraclavicular swelling that I got the day after the 2nd vaccine changed to adenocarcinoma.
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-23Pfizer-BioNTech
22021-01-11Pfizer-BioNTech

Call center

5 call center cases

5 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-24

Systemic reaction (other): Malaise, lightheaded, weak

2020-12-26

Systemic reaction (other): Dizziness

Release 1 — day 7, dose 1

2020-12-30

Systemic reaction (other): Rhinitis

Release 1 — day 14, dose 1

2021-01-06

Symptoms: Worse rhinitis and more aches and pains with a headache that doesn't seem to go away.

Release 1 — days 1–6 daily, dose 2

2021-01-12

Systemic reaction (other): Stuffie nose hard time getting breath at times

2021-01-13

Systemic reaction (other): supraclavicular lymph node Swollen (5” x 2”)

Release 2 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): supraclavicular lymph node swelling

2021-01-15

Systemic reaction (other): supraclavicular lymph node swollen

2021-01-16

Systemic reaction (other): supraclavicular lymph node Swollen

2021-01-17

Systemic reaction (other): supraclavicular lymph node swollen

Release 2 — day 7, dose 2

2021-01-18

Systemic reaction (other): supraclavicular lymph node swollen

Release 9 — 6 months, dose 2

2021-07-12

Symptoms: Constant joint pains, extreme fatigue

Release 10 — 12 months, dose 2

2022-01-11

Symptoms: Cancer the Supraclavicular swelling that I got the day after the 2nd vaccine changed to adenocarcinoma.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAdenocarcinoma · · ✓
SDArthralgia ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDNeoplasm malignant · · ✓
SDPain ✓ ✓ ✓
SDRhinitis ✓ ✓ ✓
SDSwelling · · ✓
SROAsthenia ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SROMalaise ✓ ✓ ✓
SRONasal congestion ✓ ✓ ✓
SRORhinitis ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release